Inventor · Stintenberger Straße, CH

Jan Grimm

45Patents
8h-index
47Co-inventors
71Inventor score

Filing activity: Aug 1, 2005 → Nov 22, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US8940272B2 Human anti-tau antibodies Physics 27 Active
US8906367B2 Method of providing disease-specific binding molecules and targets Chemistry; Metallurgy 18 Active
US8940276B2 Human anti-alpha-synuclein antibodies Physics 17 Active
US7927594B2 Antibodies directed against amyloid-beta peptide Chemistry; Metallurgy 16 Expired
US9598484B2 Human anti-tau antibodies Physics 12 Active
US9670272B2 Method of providing disease-specific binding molecules and targets Physics 11 Active
US9828420B2 Method of providing disease-specific binding molecules and targets Physics 11 Active
US9605059B2 Human anti-tau antibodies Physics 10 Active
US10131708B2 Methods of treating Alzheimer's disease Physics 8 Active
US9580493B2 Anti-α synuclein binding molecules Physics 8 Active
US9896504B2 Human anti-alpha-synuclein antibodies Physics 6 Active
US10202445B2 Method of providing disease-specific binding molecules and targets Physics 6 Active
US8022268B2 Transgenic animal model for alzheimer's disease Chemistry; Metallurgy 5 Active
US10259866B2 TDP-43 specific binding molecules Physics 4 Active
US9587014B2 TDP-43 specific binding molecules Physics 3 Active
US9283271B2 Human anti-SOD1 antibodies Physics 3 Active
US10874725B2 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders Emerging Cross-Sectional Technologies 3 Active
US9370531B2 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders Emerging Cross-Sectional Technologies 3 Active
US7807165B2 Antibodies directed against amyloid-beta peptide and methods using same Chemistry; Metallurgy 2 Active
US10301381B2 Anti-alpha synuclein binding molecules Physics 2 Active
US9771413B2 Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases Emerging Cross-Sectional Technologies 2 Active
US9975947B2 Anti-alpha synuclein binding molecules Physics 2 Active
US10450365B2 Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases Emerging Cross-Sectional Technologies 2 Active
US10392447B2 Human-derived anti-dipeptide repeats (DPRs) antibody Physics 1 Active
US10882902B2 Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof Physics 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.